Chairs

  • Emily Breidbart
  • Sowmya Krishnan

BOD Liaison

Laurie Cohen

Charged with keeping the Society informed on topics about both new and existing drugs and devices. To review problems related to the therapeutics of Pediatric Endocrine disorders and report to the Board of Directors and the greater membership of PES.

New Meds and Tech from the PES Drugs and Therapeutics committee: Dexcom G7
March 3, 2023

Dexcom G7   In December 2022, the Dexcom G7 continuous…

New Drugs and Therapeutics Update: Wegovy®
March 3, 2023

Wegovy® (semaglutide) once weekly injection is a glucagon-like peptide 1…

Brief updates from PES D&T Committee
March 3, 2023

Difficulty filling prescriptions for diazoxide have been reported intermittently. Teva…